Jeffrey A. Frelinger - Publications

Affiliations: 
Microbiology and Immunology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Immunology, Microbiology Biology

166 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vincent BG, File DM, McKinnon KP, Moore DT, Frelinger JA, Collins EJ, Ibrahim JG, Bixby L, Reisdorf S, Laurie SJ, Park YA, Anders CK, Collichio FA, Muss HB, Carey LA, et al. Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors. Journal of Immunology (Baltimore, Md. : 1950). PMID 37204246 DOI: 10.4049/jimmunol.2300077  0.539
2020 Wei WZ, Gibson HM, Jacob JB, Frelinger JA, Berzofsky JA, Maeng H, Dyson G, Reyes JD, Pilon-Thomas S, Ratner S, Wei KC. Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 32796024 DOI: 10.4049/Jimmunol.2000466  0.419
2020 Shubitz LF, Powell DA, Butkiewicz CD, Lewis ML, Trinh HT, Frelinger JA, Orbach MJ, Galgiani JN. A Chronic Murine Disease Model of Coccidioidomycosis Using Coccidioides posadasii, strain 1038. The Journal of Infectious Diseases. PMID 32658292 DOI: 10.1093/Infdis/Jiaa419  0.314
2019 Powell DA, Shubitz LF, Hsu A, Davis J, Holland SM, Berghout J, Lussier YA, Frelinger JA, Galgiani JN. 2888. STAT4 Mutation in Three Generations with Disseminated Coccidioidomycosis (DCM) also Exhibits Increased Susceptibility to Coccidioidal Infection in Transfected Mice Open Forum Infectious Diseases. 6: S77-S78. DOI: 10.1093/Ofid/Ofz359.166  0.32
2018 Smithey MJ, Venturi V, Davenport MP, Buntzman AS, Vincent BG, Frelinger JA, Nikolich-Žugich J. Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 29967140 DOI: 10.1073/Pnas.1719451115  0.685
2018 Shubitz LF, Powell DA, Trinh HT, Lewis ML, Orbach MJ, Frelinger JA, Galgiani JN. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity. Vaccine. PMID 29724507 DOI: 10.1016/J.Vaccine.2018.04.026  0.351
2017 Powell DA, Frelinger JA. Efficacy of Resistance to Francisella Imparted by ITY/NRAMP/SLC11A1 Depends on Route of Infection. Frontiers in Immunology. 8: 206. PMID 28360906 DOI: 10.3389/Fimmu.2017.00206  0.309
2016 Narra HP, Shubitz LF, Mandel MA, Trinh HT, Griffin K, Buntzman AS, Frelinger JA, Galgiani JN, Orbach MJ. A Coccidioides CPS1 deletion mutant is avirulent and protects mice from lethal infection. Infection and Immunity. PMID 27481239 DOI: 10.1128/Iai.00633-16  0.303
2015 Vincent B, Buntzman A, Hopson B, McEwen C, Cowell L, Akoglu A, Zhang H, Frelinger J. iWAS - A novel approach to analyzing Next Generation Sequence data for immunology. Cellular Immunology. PMID 26547365 DOI: 10.1016/J.Cellimm.2015.10.012  0.63
2015 Powell DA, Roberts LM, Ledvina HE, Sempowski GD, Curtiss R, Frelinger JA. Distinct innate responses are induced by attenuated Salmonella enterica serovar Typhimurium mutants. Cellular Immunology. PMID 26546408 DOI: 10.1016/J.Cellimm.2015.10.002  0.301
2015 Roberts LM, Ledvina HE, Tuladhar S, Rana D, Steele SP, Sempowski GD, Frelinger JA. Depletion of alveolar macrophages in CD11c diphtheria toxin receptor mice produces an inflammatory response. Immunity, Inflammation and Disease. 3: 71-81. PMID 26029367 DOI: 10.1002/Iid3.51  0.351
2015 Hunsucker SA, McGary CS, Vincent BG, Enyenihi AA, Waugh JP, McKinnon KP, Bixby LM, Ropp PA, Coghill JM, Wood WA, Gabriel DA, Sarantopoulos S, Shea TC, Serody JS, Alatrash G, ... ... Frelinger JA, et al. Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire. Cancer Immunology Research. 3: 228-35. PMID 25576336 DOI: 10.1158/2326-6066.Cir-14-0001  0.756
2014 Roberts LM, Ledvina HE, Sempowski GD, Frelinger JA. TLR2 Signaling is Required for the Innate, but Not Adaptive Response to LVS clpB. Frontiers in Immunology. 5: 426. PMID 25250027 DOI: 10.3389/Fimmu.2014.00426  0.31
2014 Roberts LM, Davies JS, Sempowski GD, Frelinger JA. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection. Vaccine. 32: 3595-603. PMID 24837506 DOI: 10.1016/J.Vaccine.2014.05.013  0.387
2014 Roberts LM, Tuladhar S, Steele SP, Riebe KJ, Chen CJ, Cumming RI, Seay S, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA. Identification of early interactions between Francisella and the host. Infection and Immunity. 82: 2504-10. PMID 24686053 DOI: 10.1128/Iai.01654-13  0.347
2014 Phillippi J, Xie Y, Miller DR, Bell TA, Zhang Z, Lenarcic AB, Aylor DL, Krovi SH, Threadgill DW, Pardo-Manuel De Villena F, Wang W, Valdar W, Frelinger JA. Using the emerging Collaborative Cross to probe the immune system Genes and Immunity. 15: 38-46. PMID 24195963 DOI: 10.1038/Gene.2013.59  0.412
2013 Hess SM, Young EF, Miller KR, Vincent BG, Buntzman AS, Collins EJ, Frelinger JA, Hess PR. Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance. Transplant Immunology. 29: 138-45. PMID 24161680 DOI: 10.1016/J.Trim.2013.10.005  0.727
2013 Holmes JC, Holmer SG, Ross P, Buntzman AS, Frelinger JA, Hess PR. Polymorphisms and tissue expression of the feline leukocyte antigen class I loci FLAI-E, FLAI-H, and FLAI-K. Immunogenetics. 65: 675-89. PMID 23812210 DOI: 10.1007/S00251-013-0711-Z  0.393
2013 Barrigan LM, Tuladhar S, Brunton JC, Woolard MD, Chen CJ, Saini D, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response. Infection and Immunity. 81: 2028-42. PMID 23529616 DOI: 10.1128/Iai.00207-13  0.761
2013 Woolard MD, Barrigan LM, Fuller JR, Buntzman AS, Bryan J, Manoil C, Kawula TH, Frelinger JA. Identification of Francisella novicida mutants that fail to induce prostaglandin E(2) synthesis by infected macrophages. Frontiers in Microbiology. 4: 16. PMID 23403609 DOI: 10.3389/Fmicb.2013.00016  0.751
2012 Holl EK, Roney KE, Allen IC, Steinbach E, Arthur JC, Buntzman A, Plevy S, Frelinger J, Ting JP. Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production. Plos One. 7: e43333. PMID 22916243 DOI: 10.1371/Journal.Pone.0043333  0.766
2012 Bunztman A, Vincent BG, Krovi H, Steele S, Frelinger JA. The LCMV gp33-specific memory T cell repertoire narrows with age. Immunity & Ageing : I & A. 9: 17. PMID 22894656 DOI: 10.1186/1742-4933-9-17  0.701
2012 Ross P, Buntzman AS, Vincent BG, Grover EN, Gojanovich GS, Collins EJ, Frelinger JA, Hess PR. Allelic diversity at the DLA-88 locus in Golden Retriever and Boxer breeds is limited. Tissue Antigens. 80: 175-83. PMID 22571293 DOI: 10.1111/J.1399-0039.2012.01889.X  0.33
2011 Valentino MD, Abdul-Alim CS, Maben ZJ, Skrombolas D, Hensley LL, Kawula TH, Dziejman M, Lord EM, Frelinger JA, Frelinger JG. A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens. Journal of Immunological Methods. 373: 111-26. PMID 21872603 DOI: 10.1016/J.Jim.2011.08.007  0.477
2011 Whitfield-Larry F, Young EF, Talmage G, Fudge E, Azam A, Patel S, Largay J, Byrd W, Buse J, Calikoglu AS, Shultz LD, Frelinger JA. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells. Diabetes. 60: 1726-33. PMID 21521873 DOI: 10.2337/Db10-1287  0.357
2011 Valentino MD, Maben ZJ, Hensley LL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG. Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets. Immunology. 132: 348-60. PMID 21214540 DOI: 10.1111/J.1365-2567.2010.03387.X  0.464
2010 Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. Journal of Immunology (Baltimore, Md. : 1950). 184: 5791-801. PMID 20393138 DOI: 10.4049/Jimmunol.1000362  0.427
2010 Vincent BG, Young EF, Buntzman AS, Stevens R, Kepler TB, Tisch RM, Frelinger JA, Hess PR. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. Journal of Immunology (Baltimore, Md. : 1950). 184: 4196-204. PMID 20220085 DOI: 10.4049/Jimmunol.0903931  0.705
2010 Lindesmith LC, Donaldson E, Leon J, Moe CL, Frelinger JA, Johnston RE, Weber DJ, Baric RS. Heterotypic humoral and cellular immune responses following Norwalk virus infection. Journal of Virology. 84: 1800-15. PMID 20007270 DOI: 10.1128/Jvi.02179-09  0.36
2009 Li L, He Q, Garland A, Yi Z, Aybar LT, Kepler TB, Frelinger JA, Wang B, Tisch R. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. Journal of Immunology (Baltimore, Md. : 1950). 183: 7585-91. PMID 19917704 DOI: 10.4049/Jimmunol.0901587  0.461
2009 Young EF, Hess PR, Arnold LW, Tisch R, Frelinger JA. Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct. Autoimmunity. 42: 678-91. PMID 19886740 DOI: 10.3109/08916930903213993  0.386
2009 Li C, Goudy K, Hirsch M, Asokan A, Fan Y, Alexander J, Sun J, Monahan P, Seiber D, Sidney J, Sette A, Tisch R, Frelinger J, Samulski RJ. Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proceedings of the National Academy of Sciences of the United States of America. 106: 10770-4. PMID 19541644 DOI: 10.1073/Pnas.0902269106  0.419
2009 Valentino MD, Hensley LL, Skrombolas D, McPherson PL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Molecular Immunology. 46: 1830-8. PMID 19233475 DOI: 10.1016/J.Molimm.2009.01.008  0.461
2008 Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infection and Immunity. 76: 5843-52. PMID 18852251 DOI: 10.1128/Iai.01176-08  0.353
2008 Frelinger JA. Novel epitope begets a novel pathway in type 1 diabetes progression. The Journal of Clinical Investigation. 118: 3268-71. PMID 18802485 DOI: 10.1172/Jci37125  0.474
2008 Li L, Wang B, Frelinger JA, Tisch R. T-cell promiscuity in autoimmune diabetes. Diabetes. 57: 2099-106. PMID 18492786 DOI: 10.2337/Db08-0383  0.387
2008 Riddle DS, Miller PJ, Vincent BG, Kepler TB, Maile R, Frelinger JA, Collins EJ. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II. European Journal of Immunology. 38: 1511-21. PMID 18465769 DOI: 10.1002/Eji.200737710  0.701
2008 Woolard MD, Hensley LL, Kawula TH, Frelinger JA. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infection and Immunity. 76: 2651-9. PMID 18391003 DOI: 10.1128/Iai.01412-07  0.41
2008 Vincent BG, Young EF, Stevens R, Buntzman AS, Kepler TB, Frelinger JA. Diversity of a diabetegenic T cell population decreases with age in pre‐diabetic NOD mice The Faseb Journal. 22: 462-462. DOI: 10.1096/Fasebj.22.2_Supplement.462  0.365
2007 Tian S, Maile R, Collins EJ, Frelinger JA. CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. Journal of Immunology (Baltimore, Md. : 1950). 179: 2952-60. PMID 17709510 DOI: 10.4049/Jimmunol.179.5.2952  0.468
2007 Woolard MD, Wilson JE, Hensley LL, Jania LA, Kawula TH, Drake JR, Frelinger JA. Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. Journal of Immunology (Baltimore, Md. : 1950). 178: 2065-74. PMID 17277110 DOI: 10.4049/Jimmunol.178.4.2065  0.449
2007 Wong CP, Stevens R, Long B, Li L, Wang Y, Wallet MA, Goudy KS, Frelinger JA, Tisch R. Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets. Journal of Immunology (Baltimore, Md. : 1950). 178: 1388-95. PMID 17237386 DOI: 10.4049/Jimmunol.178.3.1388  0.458
2007 Hess PR, Barnes C, Woolard MD, Johnson MD, Cullen JM, Collins EJ, Frelinger JA. Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin. Blood. 109: 3300-7. PMID 17179221 DOI: 10.1182/Blood-2006-06-028001  0.522
2007 Zhang TP, Jin DY, Wardrop RM, Gui T, Maile R, Frelinger JA, Stafford DW, Monahan PE. Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice. Gene Therapy. 14: 429-40. PMID 17066096 DOI: 10.1038/Sj.Gt.3302881  0.321
2006 Buchanan IB, Maile R, Frelinger JA, Fair JH, Meyer AA, Cairns BA. The effect of burn injury on CD8+ and CD4+ T cells in an irradiation model of homeostatic proliferation. The Journal of Trauma. 61: 1062-8. PMID 17099510 DOI: 10.1097/01.Ta.0000195984.56153.21  0.438
2006 Cairns B, Maile R, Barnes CM, Frelinger JA, Meyer AA. Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. The Journal of Trauma. 61: 293-8; discussion 29. PMID 16917441 DOI: 10.1097/01.Ta.0000228969.46633.Bb  0.419
2006 Maile R, Barnes CM, Nielsen AI, Meyer AA, Frelinger JA, Cairns BA. Lymphopenia-induced homeostatic proliferation of CD8+ T cells is a mechanism for effective allogeneic skin graft rejection following burn injury. Journal of Immunology (Baltimore, Md. : 1950). 176: 6717-26. PMID 16709831 DOI: 10.4049/Jimmunol.176.11.6717  0.442
2006 Wong CP, Li L, Frelinger JA, Tisch R. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice. Journal of Immunology (Baltimore, Md. : 1950). 176: 1637-44. PMID 16424193 DOI: 10.4049/Jimmunol.176.3.1637  0.46
2006 Maile R, Pop SM, Tisch R, Collins EJ, Cairns BA, Frelinger JA. Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen. European Journal of Immunology. 36: 397-410. PMID 16402405 DOI: 10.1002/Eji.200535064  0.524
2006 Maile R, Barnes CM, Frelinger JA, Meyer AA, Cairns BA. CD8+ T Cells Have a Decreased Requirement for Activation Late After Burn Injury Journal of Burn Care & Research. 27: S125. DOI: 10.1097/01253092-200603001-00153  0.399
2006 Cairns B, Maile R, Barnes C, Frelinger J, Meyer A. Lymphocyte apoptosis is required to generate memory CD8+ T cells with enhanced in vivo activity late after burn injury Journal of Surgical Research. 130: 215. DOI: 10.1016/J.Jss.2005.11.151  0.4
2005 Cowley SC, Hamilton E, Frelinger JA, Su J, Forman J, Elkins KL. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. The Journal of Experimental Medicine. 202: 309-19. PMID 16027239 DOI: 10.1084/Jem.20050569  0.471
2005 Johnston RE, Johnson PR, Connell MJ, Montefiori DC, West A, Collier ML, Cecil C, Swanstrom R, Frelinger JA, Davis NL. Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660. Vaccine. 23: 4969-79. PMID 16005121 DOI: 10.1016/J.Vaccine.2005.05.034  0.361
2005 Lindesmith L, Moe C, LePendu J, Frelinger JA, Treanor J, Baric RS. Cellular and humoral immunity following snow mountain virus challenge Journal of Virology. 79: 2900-2909. PMID 15709009 DOI: 10.1128/Jvi.79.5.2900-2909.2005  0.386
2005 Fair JH, Cairns BA, Lapaglia MA, Caballero M, Pleasant WA, Hatada S, Kim HS, Gui T, Pevny L, Meyer AA, Stafford DW, Smithies O, Frelinger JA. Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro. Proceedings of the National Academy of Sciences of the United States of America. 102: 2958-63. PMID 15699326 DOI: 10.1073/Pnas.0409840102  0.309
2005 Maile R, Siler CA, Kerry SE, Midkiff KE, Collins EJ, Frelinger JA. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. Journal of Immunology (Baltimore, Md. : 1950). 174: 619-27. PMID 15634879 DOI: 10.4049/Jimmunol.174.2.619  0.807
2005 Kerry SE, Maile R, Collins EJ, Frelinger JA. Memory CD8 T cells require CD8 coreceptor engagement for calcium mobilization and proliferation, but not cytokine production. Immunology. 114: 44-52. PMID 15606794 DOI: 10.1111/J.1365-2567.2004.02070.X  0.804
2004 Stumbles PA, Himbeck R, Frelinger JA, Collins EJ, Lake RA, Robinson BW. Cutting edge: tumor-specific CTL are constitutively cross-armed in draining lymph nodes and transiently disseminate to mediate tumor regression following systemic CD40 activation. Journal of Immunology (Baltimore, Md. : 1950). 173: 5923-8. PMID 15528325 DOI: 10.4049/Jimmunol.173.10.5923  0.359
2004 Dees EC, McKinnon KP, Kuhns JJ, Chwastiak KA, Sparks S, Myers M, Collins EJ, Frelinger JA, Van Deventer H, Collichio F, Carey LA, Brecher ME, Graham M, Earp HS, Serody JS. Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer. Cancer Immunology, Immunotherapy : Cii. 53: 777-85. PMID 15185007 DOI: 10.1007/S00262-004-0520-1  0.588
2003 Kerry SE, Buslepp J, Cramer LA, Maile R, Hensley LL, Nielsen AI, Kavathas P, Vilen BJ, Collins EJ, Frelinger JA. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. Journal of Immunology (Baltimore, Md. : 1950). 171: 4493-503. PMID 14568922 DOI: 10.4049/Jimmunol.171.9.4493  0.799
2003 Greenwood R, Wang B, Midkiff K, White GC, Lin HF, Frelinger JA. Identification of T-cell epitopes in clotting factor IX and lack of tolerance in inbred mice. Journal of Thrombosis and Haemostasis : Jth. 1: 95-102. PMID 12871545 DOI: 10.1046/J.1538-7836.2003.00001.X  0.428
2003 Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, Frelinger JA, Robinson BW. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 4905-13. PMID 12734333 DOI: 10.4049/Jimmunol.170.10.4905  0.395
2003 Buslepp J, Kerry SE, Loftus D, Frelinger JA, Appella E, Collins EJ. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC. Journal of Immunology (Baltimore, Md. : 1950). 170: 373-83. PMID 12496422 DOI: 10.4049/Jimmunol.170.1.373  0.795
2003 Buchanan IB, Maile R, Frelinger JA, Meyer AA, Cairns BA. The Effect of Burn Injury on Homeostatic Proliferation of CD4+ and CD8+ T Cells Journal of Burn Care & Rehabilitation. 24: S72. DOI: 10.1097/00004630-200303002-00060  0.398
2003 Hess P, Maile R, Kerry S, Meyer A, Frelinger J, Cairns B. Activation of intraperitoneal T cells after stimulation with antigen specific major histocompatibility class (MHC) I tetramer Journal of Surgical Research. 114: 305. DOI: 10.1016/J.Jss.2003.08.114  0.819
2003 Buchanan I, Maile R, Frelinger J, Meyer A, Cairns B. In Vivo homeostatic proliferation of purified CD4+ T cells, but not purified CD8+ T cells, is decreased early after burn injury Journal of Surgical Research. 114: 303. DOI: 10.1016/J.Jss.2003.08.107  0.462
2002 Wang B, Sharma A, Maile R, Saad M, Collins EJ, Frelinger JA. Peptidic termini play a significant role in TCR recognition. Journal of Immunology (Baltimore, Md. : 1950). 169: 3137-45. PMID 12218131 DOI: 10.4049/Jimmunol.169.6.3137  0.345
2002 Garba ML, Pilcher CD, Bingham AL, Eron J, Frelinger JA. HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 168: 2247-54. PMID 11859112 DOI: 10.4049/Jimmunol.168.5.2247  0.345
2001 Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice Clinical Immunology. 101: 51-58. PMID 11580226 DOI: 10.1006/Clim.2001.5095  0.458
2001 Maile R, Wang B, Schooler W, Meyer A, Collins EJ, Frelinger JA. Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers Journal of Immunology. 167: 3708-3714. PMID 11564786 DOI: 10.4049/Jimmunol.167.7.3708  0.461
2001 Greenwood R, Frelinger J. Mechanisms of unresponsiveness: T- and B-cell mediated mechanisms of anergy Advances in Experimental Medicine and Biology. 489: 109-117. PMID 11554585 DOI: 10.1007/978-1-4615-1277-6_10  0.38
2001 Cramer LA, Frelinger JA. Dendritic cells transduced with HIV Nef express normal levels of HLA-A and HLA-B class I molecules Journal of Acquired Immune Deficiency Syndromes. 27: 417-425. PMID 11511817 DOI: 10.1097/00126334-200108150-00001  0.414
2001 Cairns BA, Maile R, Buchanan I, Pilati D, DeSerres S, Collins EJ, Frelinger JA, Meyer AA. CD8+ T cells express a T-helper 1-like phenotype after burn injury Surgery. 130: 210-216. PMID 11490351 DOI: 10.1067/Msy.2001.115835  0.474
2001 Wang B, Norbury CC, Greenwood R, Bennink JR, Yewdell JW, Frelinger JA. Multiple paths for activation of naive CD8+ T cells: CD4-independent help Journal of Immunology. 167: 1283-1289. PMID 11466344 DOI: 10.4049/Jimmunol.167.3.1283  0.509
2000 Mylin LM, Schell TD, Roberts D, Epler M, Boesteanu A, Collins EJ, Frelinger JA, Joyce S, Tevethia SS. Quantitation of CD8+ T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes Journal of Virology. 74: 6922-6934. PMID 10888631 DOI: 10.1128/Jvi.74.15.6922-6934.2000  0.52
2000 Wu YP, McMahon E, Kraine MR, Tisch R, Meyers A, Frelinger J, Matsushima GK, Suzuki K. Distribution and characterization of GFP(+) donor hematogenous cells in Twitcher mice after bone marrow transplantation. The American Journal of Pathology. 156: 1849-54. PMID 10854208 DOI: 10.1016/S0002-9440(10)65058-4  0.31
2000 Serody JS, Collins EJ, Tisch RM, Kuhns JJ, Frelinger JA. T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery Journal of Immunology. 164: 4961-4967. PMID 10779807 DOI: 10.4049/Jimmunol.164.9.4961  0.586
2000 Wang B, Maile R, Greenwood R, Collins EJ, Frelinger JA. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells Journal of Immunology. 164: 1216-1222. PMID 10640733 DOI: 10.4049/Jimmunol.164.3.1216  0.471
2000 Cairns BA, Maile R, Schooler WG, Frelinger JA, Meyer AA. Modulation of immune response with MHC class i allotetramers Journal of the American College of Surgeons. 191: S49. DOI: 10.1016/S1072-7515(00)00524-X  0.332
1999 Kirksey TJ, Pogue-Caley RR, Frelinger JA, Collins EJ. The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes Journal of Biological Chemistry. 274: 37259-37264. PMID 10601290 DOI: 10.1074/Jbc.274.52.37259  0.358
1999 Caley RRP, Peace-Brewer AL, Matsui M, Frelinger JA. Analysis of the mutant HLA-A*0201 heavy chain H74L: Impaired TAP- dependent peptide loading Human Immunology. 60: 743-754. PMID 10527381 DOI: 10.1016/S0198-8859(99)00022-1  0.34
1999 Caley IJ, Betts MR, Davis NL, Swanstrom R, Frelinger JA, Johnston RE. Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy. Vaccine. 17: 3124-35. PMID 10462249 DOI: 10.1016/S0264-410X(99)00142-5  0.307
1999 Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Murine T Lymphocytes Incapable of Producing Macrophage Inhibitory Protein-1 Are Impaired in Causing Graft-Versus-Host Disease Across a Class I But Not Class II Major Histocompatibility Complex Barrier Blood. 93: 43-50. DOI: 10.1182/blood.v93.1.43.401k24_43_50  0.555
1999 Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Murine T Lymphocytes Incapable of Producing Macrophage Inhibitory Protein-1 Are Impaired in Causing Graft-Versus-Host Disease Across a Class I But Not Class II Major Histocompatibility Complex Barrier Blood. 93: 43-50. DOI: 10.1182/Blood.V93.1.43  0.601
1998 Hunt JP, Hunter CT, Brownstein MR, Giannopoulos A, Hultman CS, deSerres S, Bracey L, Frelinger J, Meyer AA. The effector component of the cytotoxic T-lymphocyte response has a biphasic pattern after burn injury. The Journal of Surgical Research. 80: 243-51. PMID 9878320 DOI: 10.1006/Jsre.1998.5488  0.362
1998 Collins EJ, Frelinger JA. Altered peptide ligand design: Altering immune responses to class I MHC/peptide complexes Immunological Reviews. 163: 151-160. PMID 9700508 DOI: 10.1111/J.1600-065X.1998.Tb01194.X  0.318
1998 Hultman CS, Hunt JP, Yamamoto H, Giannopoulos A, DeSerres S, Frelinger JA, Meyer AA. Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens Journal of Trauma - Injury, Infection and Critical Care. 45: 25-34. PMID 9680007 DOI: 10.1097/00005373-199807000-00005  0.318
1998 Frelinger JA, Serody J. Immune response of β2-microglobulin-deficient mice to pathogens Current Topics in Microbiology and Immunology. 232: 99-114. PMID 9557395 DOI: 10.1007/978-3-642-72045-1_5  0.68
1997 Quinn DG, Zajac AJ, Hioe CE, Frelinger JA. Virus-specific, CD8+ major histocompatibility complex class I- restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus- infected β2-microglobulin-deficient mice Journal of Virology. 71: 8392-8396. PMID 9343195 DOI: 10.1128/Jvi.71.11.8392-8396.1997  0.411
1997 Hultman CS, Yamamoto H, DeSerres S, Frelinger JA, Meyer AA. Early but not late burn wound excision partially restores viral-specific T lymphocyte cytotoxicity Journal of Trauma - Injury, Infection and Critical Care. 43: 441-447. PMID 9314305 DOI: 10.1097/00005373-199709000-00009  0.319
1997 Serody JS, Brecher ME, Dent G, Bentley SA, Frelinger JA, Shea TC. A method for the production of CD4+ chronic myelogenous leukemia- specific allogeneic T lymphocytes Cancer Research. 57: 1547-1553. PMID 9108458  0.343
1997 Caley IJ, Betts MR, Irlbeck DM, Davis NL, Swanstrom R, Frelinger JA, Johnston RE. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. Journal of Virology. 71: 3031-8. PMID 9060663 DOI: 10.1128/Jvi.71.4.3031-3038.1997  0.336
1997 Hultman CS, Hunt JP, Giannopoulos A, Yamamoto H, deSerres S, Frelinger JA, Meyer AA. Donor Keratinocytes Deficient in Class II Alloantigens Fail to Prime the Host for Accelerated Second-Set Rejection or Enhanced Cytotoxic T Lymphocyte Activity The Journal of Trauma: Injury, Infection, and Critical Care. 43: 204. DOI: 10.1097/00005373-199707000-00108  0.371
1996 Zajac AJ, Quinn DG, Cohen PL, Frelinger JA. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection Proceedings of the National Academy of Sciences of the United States of America. 93: 14730-14735. PMID 8962123 DOI: 10.1073/Pnas.93.25.14730  0.429
1996 Serody JS, Poston RM, Weinstock D, Kurlander RJ, Frelinger JA. CD4+ cytolytic effecters are inefficient in the clearance of Listeria monocytogenes Immunology. 88: 544-550. PMID 8881755 DOI: 10.1046/J.1365-2567.1996.D01-698.X  0.623
1996 Peace-Brewer AL, Tussey LG, Matsui M, Li G, Quinn DG, Frelinger JA. A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL Immunity. 4: 505-514. PMID 8630735 DOI: 10.1016/S1074-7613(00)80416-1  0.353
1996 Matsui M, Warburton RJ, Cogswell PC, Baldwin AS, Frelinger JA. Effects of HIV-1 Tat on expression of HLA class I molecules. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 11: 233-40. PMID 8603259 DOI: 10.1097/00042560-199603010-00003  0.367
1995 Quinn DG, Zajac AJ, Frelinger JA. The cell-mediated immune response against lymphocytic choriomeningitis virus in β2-microglobulin deficient mice Immunological Reviews. 151-169. PMID 8825286 DOI: 10.1111/J.1600-065X.1995.Tb00097.X  0.359
1995 Zajac AJ, Muller D, Pederson K, Frelinger JA, Quinn DG. Natural killer cell activity in lymphocytic choriomeningitis virus-infected β2-microglobulin-deficient mice International Immunology. 7: 1545-1556. PMID 8562499 DOI: 10.1093/Intimm/7.10.1545  0.398
1995 Hultman CS, Cairns BA, deSerres S, Frelinger JA, Meyer AA. Early, complete burn wound excision partially restores cytotoxic T lymphocyte function Surgery. 118: 421-430. PMID 7638760 DOI: 10.1016/S0039-6060(05)80354-X  0.317
1995 Pogue RR, Eron J, Frelinger JA, Matsui M. Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity Proceedings of the National Academy of Sciences of the United States of America. 92: 8166-8170. PMID 7545295 DOI: 10.1073/Pnas.92.18.8166  0.407
1995 Hioe CE, Frelinger JA. Alterations of a dominant epitope of lymphocytic choriomeningitis virus which affect class I binding and cytotoxic T cell recognition Molecular Immunology. 32: 725-731. PMID 7544868 DOI: 10.1016/0161-5890(95)00040-L  0.375
1995 Tussey LG, Rowland-Jones S, Zheng TS, Androlewicz MJ, Cresswell P, Frelinger JA, McMichael AJ. Different MHC class I alleles compete for presentation of overlapping viral epitopes Immunity. 3: 65-77. PMID 7542549 DOI: 10.1016/1074-7613(95)90159-0  0.38
1994 Warburton RJ, Matsui M, Rowland-Jones SL, Gammon MC, Katzenstein GE, Wei T, Edidin M, Zweerink HJ, McMichael AJ, Frelinger JA. Mutation of the α2 domain disulfide bridge of the class I molecule HLA-A*0201 Effect on maturation and peptide presentation Human Immunology. 39: 261-271. PMID 8071101 DOI: 10.1016/0198-8859(94)90269-0  0.348
1994 Matsushima GK, Taniike M, Glimcher LH, Grusby MJ, Frelinger JA, Suzuki K, Ting JP. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell. 78: 645-56. PMID 8069913 DOI: 10.1016/0092-8674(94)90529-0  0.579
1994 Matsui M, Moots RJ, McMichael AJ, Frelinger JA. Significance of the six peptide-binding pockets of HLA-A2.1 in influenza a matrix peptide-specific cytotoxic T-lymphocyte reactivity Human Immunology. 41: 160-166. PMID 7860362 DOI: 10.1016/0198-8859(94)90010-8  0.361
1994 Hioe CE, McKinney DM, Frelinger JA, McMillan M. Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affects CTL recognition and binding of the nucleoprotein peptide from the lymphocytic chroriomeningitis Immunogenetics. 40: 222-229. PMID 7518804 DOI: 10.1007/Bf00167083  0.319
1994 Cairns BA, deSerres S, Matsui M, Frelinger JA, Meyer AA. CULTURED MOUSE KERATINOCYTE ALLOGRAFTS PRIME FOR ACCELERATED SECOND SET REJECTION AND ENHANCED CYTOTOXIC LYMPHOCYTE RESPONSE1,2 Transplantation. 58: 67-71. DOI: 10.1097/00007890-199407000-00012  0.316
1993 Quinn DG, Zajac AJ, Frelinger JA, Muller D. Transfer of lymphocytic choriomeningitis disease in β2-microglobulin-deficient mice by CD4+ T cells International Immunology. 5: 1193-1198. PMID 7903551 DOI: 10.1093/Intimm/5.10.1193  0.464
1993 Colbert RA, Rowland-Jones SL, Mcmichael AJ, Frelinger JA. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide Proceedings of the National Academy of Sciences of the United States of America. 90: 6879-6883. PMID 7688130 DOI: 10.1073/Pnas.90.14.6879  0.355
1993 Matsui M, Hioe CE, Frelinger JA. Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones Proceedings of the National Academy of Sciences of the United States of America. 90: 674-678. PMID 7678462 DOI: 10.1073/Pnas.90.2.674  0.359
1992 Lapan KE, Klapper DG, Frelinger JA. Production and characterization of two new mouse monoclonal antibodies reactive with denatured mouse class II beta chains Hybridoma. 11: 217-223. PMID 1376718 DOI: 10.1089/Hyb.1992.11.217  0.344
1992 Muller D, Koller BH, Whitton JL, Lapan KE, Brigman KK, Frelinger JA. LCMV-specific, class II-restricted cytotoxic T cells in β2-microglobulin-deficient mice Science. 255: 1576-1578. PMID 1347959 DOI: 10.1126/Science.1347959  0.467
1991 Harton JA, Litaker W, Frelinger JA, Bishop GA. Structure function analysis of the H-2 Abp gene. Immunogenetics. 34: 358-65. PMID 1748486 DOI: 10.1007/Bf01787485  0.315
1991 LaPan KE, Klapper DG, Frelinger JA. Production and characterization of a peptide specific, anti-major histocompatibility complex class II, monoclonal antibody Molecular Immunology. 28: 499-504. PMID 1648172 DOI: 10.1016/0161-5890(91)90164-F  0.359
1990 Heath WR, Hurd ME, Murray R, Frelinger J, Sherman LA. Analysis of novel residues of class I involved in recognition by alloreactive T cells Immunogenetics. 32: 138-141. PMID 2397933 DOI: 10.1007/Bf00210452  0.412
1990 Alexander J, Payne JA, Shigekawa B, Frelinger JA, Cresswell P. The transport of class I major histocompatibility complex antigens is determined by sequences in the α1 and α2 protein domains Immunogenetics. 31: 169-178. PMID 2318516 DOI: 10.1007/Bf00211552  0.396
1990 Bishop GA, Pennell CA, Travis W, Haughton G, Frelinger JA. Antibodies specific for Ig idiotype, but not isotype, can substitute for antigen to induce IgM secretion by a B cell clone. International Immunology. 2: 285-90. PMID 2278988 DOI: 10.1093/Intimm/2.4.285  0.332
1990 Murray R, Katoh K, Alexander J, Muller D, Pederson K, Frelinger JA. Mutations in the α1 domain of a class I gene define residues important for specific allorecognition Cellular Immunology. 128: 220-230. PMID 1693100 DOI: 10.1016/0008-8749(90)90020-R  0.395
1989 Bishop GA, Frelinger JA. Haplotype-specific differences in signaling by transfected class II molecules to a Ly-1+ B-cell clone. Proceedings of the National Academy of Sciences of the United States of America. 86: 5933-7. PMID 2788281 DOI: 10.1073/Pnas.86.15.5933  0.346
1989 Matsushima GK, Gilmore W, Casteel N, Frelinger JA, Stohlman SA. Evidence for a subpopulation of antigen-presenting cells specific for the induction of the delayed-type hypersensitivity response Cellular Immunology. 119: 171-181. PMID 2784078 DOI: 10.1016/0008-8749(89)90233-5  0.459
1989 Alexander J, Payne JA, Murray R, Frelinger JA, Cresswell P. Differential transport requirements of HLA and H-2 class I glycoproteins Immunogenetics. 29: 380-388. PMID 2731965 DOI: 10.1007/Bf00375866  0.415
1989 Groghan TW, Davignon JL, Evans J, Allison JP, Eisenberg RA, Frelinger JA, Cohen PL. Diminished expression of the t cell receptor on the expanded lymphocyte population in mrl/mp-1pr/1pr mice Autoimmunity. 2: 97-111. PMID 2562377 DOI: 10.3109/08916938909019947  0.398
1988 Murray R, Hutchison CA, Frelinger JA. Saturation mutagenesis of a major histocompatibility complex protein domain: Identification of a single conserved amino acid important for allorecognition Proceedings of the National Academy of Sciences of the United States of America. 85: 3535-3539. PMID 3285344 DOI: 10.1073/Pnas.85.10.3535  0.42
1988 Bishop GA, McMillan MS, Haughton G, Frelinger JA. Signaling to a B-cell clone by Ek, but not Ak, does not reflect alteration of Ak genes. Immunogenetics. 28: 184-92. PMID 3137158 DOI: 10.1007/Bf00375858  0.39
1988 Jambou RC, Snouwaert JN, Bishop GA, Stebbins JR, Frelinger JA, Fowlkes DM. High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein. Proceedings of the National Academy of Sciences of the United States of America. 85: 9426-30. PMID 3059347 DOI: 10.1073/Pnas.85.24.9426  0.307
1988 Kanda T, Macchi MJ, LaPan K, Darsley M, Apperlla E, Frelinger JA. Cytotoxic T lymphocyte recognition of hybrid MHC class I molecules Journal of Immunogenetics. 15: 295-305. PMID 2475544 DOI: 10.1111/J.1744-313X.1988.Tb00433.X  0.423
1987 Ting JP, Takiguchi M, Macchi M, Frelinger JA. The expression and detection of MHC class I antigens on murine neuroblastoma and ependymoblastoma lines. Journal of Neuroimmunology. 14: 87-98. PMID 3492512 DOI: 10.1016/0165-5728(87)90103-2  0.544
1987 Kanda T, LaPan K, Takahashi H, Appella E, Frelinger JA. The α1 and α2 domains of H-2 class I molecules interact to form unique epitopes Immunogenetics. 25: 110-115. PMID 2434419 DOI: 10.1007/Bf00364276  0.387
1987 Darsley MJ, Takahashi H, Macchi MJ, Frelinger JA, Ozato K, Appella E. New family of exon-shuffled recombinant genes reveals extensive interdomain interactions in class I histocompatibility antigens and identifies residues involved Journal of Experimental Medicine. 165: 211-222. PMID 2432149 DOI: 10.1084/Jem.165.1.211  0.31
1986 Takiguchi M, Frelinger JA. Induction of antigen presentation ability in purified cultures of astroglia by interferon-γ Journal of Molecular and Cellular Immunology. 2: 269-280. PMID 3151059  0.322
1986 Matsushima GK, Harmon RC, Frelinger JA. A new murine lymphocyte alloantigen, Ly-27.2. Immunogenetics. 23: 406-8. PMID 2941364 DOI: 10.1007/Bf00372675  0.308
1985 Schepart BS, Woodward JG, Palmer MJ, Macchi MJ, Basta P, McLaughlin-Taylor E, Frelinger JA. Expression in L cells of transfected class I genes from the mouse major histocompatibility complex. Proceedings of the National Academy of Sciences of the United States of America. 82: 5505-9. PMID 2991930 DOI: 10.1073/Pnas.82.16.5505  0.423
1985 Takiguchi M, Ting JP, Buessow SC, Boyer C, Gillespie Y, Frelinger JA. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability. European Journal of Immunology. 15: 809-14. PMID 2411569 DOI: 10.1002/Eji.1830150813  0.56
1985 Frelinger JA. Perspectives in immunogenetics and histocompatibility volume 6: Lymphocyte surface antigens 1984 Immunology Today. 6: 374. DOI: 10.1016/0167-5699(85)90099-4  0.321
1984 McLaughlin-Taylor E, Woodward JG, Macchi MJ, McMillan M, Frelinger JA. Functional characterization of the H-2Dp gene product Immunogenetics. 19: 205-216. PMID 6231245 DOI: 10.1007/Bf00364764  0.314
1984 McLaughlin-Taylor E, Woodward JG, McMillan M, Frelinger JA. Distinct epitopes are recognized by cytolytic T lymphocyte clones on the same class I molecule: Direct demonstration using DNA-transfected targets and long-term cytolytic T cell clones European Journal of Immunology. 14: 969-974. PMID 6209147 DOI: 10.1002/Eji.1830141102  0.32
1984 Woodward JG, Matsushima G, Frelinger JA, Stohlman SA. Production and characterization of T cell clones specific for mouse hepatitis virus, strain JHM: In vivo and in vitro analysis Journal of Immunology. 133: 1016-1021. PMID 6203963  0.35
1983 Ting JP, Nixon DF, Weiner LP, Frelinger JA. Brain Ia antigens have a bone marrow origin. Immunogenetics. 17: 295-301. PMID 6572615 DOI: 10.1007/BF00364413  0.437
1982 Nixon DF, Ting JP, Frelinger JA. Ia antigens on non-lymphoid tissues their origins and functions. Immunology Today. 3: 339-42. PMID 25290677 DOI: 10.1016/0167-5699(82)90019-6  0.58
1982 Woodward JG, Orn A, Harmon RC, Goodenow RS, Hood L, Frelinger JA. Specific recognition of the product of a transferred major histocompatibility complex gene by cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 79: 3613-7. PMID 6980415 DOI: 10.1073/Pnas.79.11.3613  0.436
1982 Rao VS, Frelinger JA, Mitchell MS. The role of la antigens and Fc receptor-bearing T-cells in the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes Cellular Immunology. 74: 370-382. PMID 6219749 DOI: 10.1016/0008-8749(82)90037-5  0.348
1981 Ting JP, Shigekawa BL, Linthicum DS, Weiner LP, Frelinger JA. Expression and synthesis of murine immune response-associated (Ia) antigens by brain cells. Proceedings of the National Academy of Sciences of the United States of America. 78: 3170-4. PMID 6166944 DOI: 10.1073/pnas.78.5.3170  0.532
1981 Wettstein PJ, Frelinger JA. T lymphocyte responses to non-H-2 histocompatibility antigens. I. Role of Ly-1+2+ T cells as cytotoxic effectors and requirement for Ly-1+2+ T cells for optimal generation of cytotoxic effectors Journal of Immunology. 127: 43-46. PMID 6165773  0.366
1980 Jandinski JJ, Li J, Wettstein PJ, Frelinger JA, Scott DW. Role of self carriers in the immune response and tolerance. V. Reversal of trinitrophenyl-modified self suppression of the B-cell response by blocking of H-2 antigens Journal of Experimental Medicine. 151: 133-143. PMID 6444234 DOI: 10.1084/Jem.151.1.133  0.398
1979 Frelinger JG, Hood L, Hill S, Frelinger JA. Mouse epidermal Ia molecules have a bone marrow origin [29] Nature. 282: 321-323. PMID 503207 DOI: 10.1038/282321A0  0.339
1979 Frelinger JA, Wettstein PJ. Expression of lymphocyte differentiation antigens on cells responsive to H-2 mutant alloantigens Res Journal of the Reticuloendothelial Society. 26: 597-599. PMID 160453  0.303
1979 Wettstein PJ, Bailey DW, Mobraaten LE, Klein J, Frelinger JA. T lymphocyte response to H-2 mutants: Cytotoxic effectors are Ly-1 +2 + Proceedings of the National Academy of Sciences of the United States of America. 76: 3455-3459. PMID 158760 DOI: 10.1073/Pnas.76.7.3455  0.456
1978 Wettstein PJ, Bailey DW, Mobraaten LE, Klein J, Frelinger JA. T-lymphocyte response to H-2 mutants. I. Proliferation is dependent on Ly 1 +2 + cells Journal of Experimental Medicine. 147: 1395-1404. PMID 148487 DOI: 10.1084/Jem.147.5.1395  0.379
1978 Frelinger JG, Wettstein PJ, Frelinger JA, Hood L. Epidermal Ia molecules from the I-A and I-EC subregions of the mouse H-2 complex Immunogenetics. 6: 125-135. DOI: 10.1007/Bf01563903  0.34
1977 Shreffler DC, David CS, Cullen SE, Frelinger JA, Niederhuber JE. Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex Cold Spring Harbor Symposia On Quantitative Biology. 41: 477-487. PMID 302172  0.646
1977 Dugan E, Niederhuber JE, Frelinger JA, Mayo L, Shreffler DC. Con A induced suppressor cells: suppression with I region incompatibility. Cellular Immunology. 29: 322-30. PMID 301060 DOI: 10.1016/0008-8749(77)90326-4  0.68
1977 Frelinger JA. Ia bearing cells promote the concanavalin A mitogenic response of Ia negative T cells European Journal of Immunology. 7: 447-450. PMID 70362  0.309
1977 Lukasewycz OA, Frelinger JA. Immune mechanisms in leukemia. Role of the Ia antigens Journal of Experimental Medicine. 145: 1077-1081. PMID 67166  0.361
1976 Niederhuber JE, Frelinger JA, Dine MS, Shoffner P, Dugan E, Shreffler DC. Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. The Journal of Experimental Medicine. 143: 372-81. PMID 1082489 DOI: 10.1084/jem.143.2.372  0.741
1976 Frelinger JA, Niederhuber JE, Shreffler DC. Effects of anti Ia sera on mitogenic responses. III. Mapping the genes controlling the expression of Ia determinants on concanavalin A reactive cells to the I-J subregion of the H-2 gene complex Journal of Experimental Medicine. 144: 1141-1146. PMID 62014  0.715
1976 Niederhuber JE, Frelinger JA. Expression of Ia antigens on T and B cells and their relationship to immune-response functions Transplantation Reviews. 30: 101-121. PMID 59969  0.337
1976 Niederhuber JE, Frelinger JA, Dugan E, Shreffler DC. The relationship of the major murine histocompatibility region associated IA antigens to mitogen responses. The Journal of Surgical Research. 20: 563-70. PMID 59005 DOI: 10.1016/0022-4804(76)90091-3  0.685
1976 Wettstein PJ, Krammer P, Nowinski RC, David CS, Frelinger JA, Shreffler DC. A cautionary note regarding Ia and H-2 typing of murine lymphoid tumors Immunogenetics. 3: 507-516. DOI: 10.1007/BF01576980  0.641
1975 Frelinger JA, Niederhuber JE, Shreffler DC. Inhibition of immune responses in vitro by specific antiserums to Ia antigens Science. 188: 268-270. PMID 1118728  0.699
1975 Niederhuber JE, Frelinger JA, Dugan E, Coutinho A, Shreffler DC. Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. Journal of Immunology (Baltimore, Md. : 1950). 115: 1672-6. PMID 1081105  0.677
1975 Schultz JS, Frelinger JA, Kim SK, Shreffler DC. The distribution of la antigens of the H-2 complex on lymph node cells by immunoferritin labelling Cellular Immunology. 16: 125-134. PMID 1078788 DOI: 10.1016/0008-8749(75)90191-4  0.684
1975 David CS, Frelinger JA, Shreffler DC. Expression of individual Ia specificities on T and B lymphocytes Federation Proceedings. 34.  0.376
1974 Frelinger JA, Niederhuber JE, David CS, Shreffler DC. Evidence for the expression of Ia (H 2 associated) antigens on thymus derived lymphocytes Journal of Experimental Medicine. 140: 1273-1284. PMID 4547437  0.703
1974 David CS, Frelinger JA, Shreffler DC. New lymphocyte antigens controlled by the Ir-IgG region of the H-2 gene complex Transplantation. 17: 122-125. PMID 4543678  0.68
1973 David CS, Shreffler DC, Frelinger JA. New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H 2 complex Proceedings of the National Academy of Sciences of the United States of America. 70: 2509-2514. PMID 4517664  0.705
Show low-probability matches.